A type of immunotherapy called a checkpoint inhibitor. It stimulates the body’s immune system to fight cancer cells. Avelumab targets and blocks a protein called PD-L1 on the surface of certain immune cells, which activates the immune cells to find and kill cancer cells.
(866) 850-9555
help@netcancerawareness.org